NEAR-INFRARED SPECTROMETRY OF MICROORGANISMS IN LIQUID PHARMACEUTICALS

被引:16
作者
GALANTE, LJ
BRINKLEY, MA
DRENNEN, JK
LODDER, RA
机构
[1] UNIV KENTUCKY,MED CTR,COLL PHARM,LEXINGTON,KY 40536
[2] GLAXO INC,RES TRIANGLE PK,NC 27709
关键词
D O I
10.1021/ac00222a601
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Biotechnology and pharmaceutical research have created a number of new and potentially life-saving drugs. Many of these drugs are formulated as Injectable products. Some drug products do not survive autoclaving or other means of terminal sterilization. An aseptic fitting process Is typically used to sterilize such products, but It is less reliable than autoclaving, making detection of unsterile units even more essential. Invasive microbiological methods and turbldimetry are currently employed as inspection techniques. These processes are time-consuming, destroy product, and may not detect low levels of contamination. Near-IR light scattering Is proposed as a new method of determining low levels of contamination noninvasively and nondestructivey. The method is used successfully in the current study to detect contamination by a species of yeast, mold, and bacteria In intact plastic Infusion bags at levels as low as three colony-forming units per milliliter for yeast. By use of the near-IR method, each injectable unit can be evaluated with its integrity maintained, allowing the product to be dispensed or evaluated by another analytical method. © 1990, American Chemical Society. All rights reserved.
引用
收藏
页码:2514 / 2521
页数:8
相关论文
共 10 条
[1]  
Avallone H L, 1986, J Parenter Sci Technol, V40, P56
[2]  
AVALLONE H L, 1985, Journal of Parenteral Science and Technology, V39, P75
[3]  
LEE J Y, 1989, Pharmaceutical Technology, V13, P66
[4]   ANALYSIS OF INTACT TABLETS BY NEAR-INFRARED REFLECTANCE SPECTROMETRY [J].
LODDER, RA ;
HIEFTJE, GM .
APPLIED SPECTROSCOPY, 1988, 42 (04) :556-558
[5]   DETECTION OF CAPSULE TAMPERING BY NEAR-INFRARED REFLECTANCE ANALYSIS [J].
LODDER, RA ;
SELBY, M ;
HIEFTJE, GM .
ANALYTICAL CHEMISTRY, 1987, 59 (15) :1921-1930
[6]  
1987, FDA GUIDELINE STERIL
[7]  
1988, F D C REP, V22, P1
[8]  
1980, TECHNICAL MONOGRAPH, V2
[9]  
1980, TECHNICAL MONOGRAPH, V1
[10]  
1989, US PHARM CONVENTION, P1478